90 related articles for article (PubMed ID: 3679352)
1. A comparative study of the mutagenic activation of carcinogenic N-nitrosopropylamines by various animal species and man.
Mori Y; Yamazaki H; Konishi Y
IARC Sci Publ; 1987; (84):141-3. PubMed ID: 3679352
[TBL] [Abstract][Full Text] [Related]
2. Participation of phenobarbital-inducible cytochrome P450 in the mutagenic activation of N-nitrosopropylamines by liver and lung 9000 g fractions from five animal species and man.
Mori Y; Konishi Y
IARC Sci Publ; 1991; (105):398-403. PubMed ID: 1855888
[TBL] [Abstract][Full Text] [Related]
3. Activation of carcinogenic N-nitrosopropylamines to mutagens by lung and pancreas S9 fractions from various animal species and man.
Mori Y; Yamazaki H; Toyoshi K; Maruyama H; Konishi Y
Mutat Res; 1986 May; 160(3):159-69. PubMed ID: 3960034
[TBL] [Abstract][Full Text] [Related]
4. Mutagenic activation of carcinogenic N-nitrosopropylamines by liver S9 fractions from mice, rats and hamsters: evidence for a cytochrome P-450-dependent reaction.
Mori Y; Yamazaki H; Toyoshi K; Denda A; Konishi Y
Carcinogenesis; 1986 Mar; 7(3):375-9. PubMed ID: 3512116
[TBL] [Abstract][Full Text] [Related]
5. A comparative study of the mutagenic activation of N-nitrosopropylamines by various animal species and man: evidence for a cytochrome P-450 dependent reaction.
Yamazaki H; Mori Y; Toyoshi K; Nagai H; Koda A; Konishi Y
Jpn J Cancer Res; 1986 Feb; 77(2):107-17. PubMed ID: 3082822
[TBL] [Abstract][Full Text] [Related]
6. Mutagenic activation of carcinogenic N-nitrosopropylamines by rat liver: evidence for a cytochrome P-450 dependent reaction.
Mori Y; Yamazaki H; Toyoshi K; Makino T; Obara T; Yokose Y; Konishi Y
Carcinogenesis; 1985 Mar; 6(3):415-20. PubMed ID: 3884171
[TBL] [Abstract][Full Text] [Related]
7. Lung carcinogenesis by N-nitrosobis(2-hydroxypropyl)amine-related compounds and their formation in rats.
Konishi Y; Yokose Y; Mori Y; Yamazaki H; Yamamoto K; Nakajima A; Denda A
IARC Sci Publ; 1987; (84):250-2. PubMed ID: 3679377
[TBL] [Abstract][Full Text] [Related]
8. Mutagenicity of N-nitrosobis(2-hydroxypropyl)amine and its related compounds in the presence of rat lung and liver S9.
Mori Y; Niwa T; Takahashi H; Toyoshi K; Denda A; Takahashi S; Konishi Y
Cancer Lett; 1983 Apr; 18(3):271-5. PubMed ID: 6406040
[TBL] [Abstract][Full Text] [Related]
9. Species specificity in the metabolism of N-nitrosobis(2-oxopropyl)amine and N-nitroso(2-hydroxypropyl)(2-oxopropyl)amine to mutagens by isolated rat and hamster hepatocytes.
Mangino MM; Hollenberg PF; Scarpelli DG
Cancer Res; 1987 Sep; 47(18):4776-81. PubMed ID: 3113724
[TBL] [Abstract][Full Text] [Related]
10. Activation of N-nitrosobis(2-oxopropyl)amine and N-nitroso(2-hydroxypropyl)-(2-oxopropyl)amine to mutagens for V79 cells by isolated hamster and rat pancreatic acinar cells.
Mangino MM; Scarpelli DG; Hollenberg PF
Cancer Res; 1985 Nov; 45(11 Pt 1):5219-24. PubMed ID: 4053002
[TBL] [Abstract][Full Text] [Related]
11. Comparison of the carcinogenic effectiveness of N-nitrosobis(2-hydroxypropyl)amine, N-nitrosobis(2-oxopropyl)amine, N-nitroso(2-hydroxypropyl)(2-oxopropyl)amine, and N-nitroso-2,6-dimethylmorpholine in Syrian hamsters.
Lijinsky W; Saavedra JE; Knutsen GL; Kovatch RM
J Natl Cancer Inst; 1984 Mar; 72(3):685-8. PubMed ID: 6583451
[TBL] [Abstract][Full Text] [Related]
12. Mutagenicity of several pancreatic carcinogenic derivatives of N-nitrosodipropylamine in the Ames assay.
Wislocki P; Gingell R
Mutat Res; 1980 Mar; 77(3):215-9. PubMed ID: 6991919
[TBL] [Abstract][Full Text] [Related]
13. Greater effectiveness of hepatocyte and liver S9 preparations from hamsters than rat preparations in activating N-nitroso compounds to metabolites mutagenic to Salmonella.
Raineri R; Poiley JA; Andrews AW; Pienta RJ; Lijinsky W
J Natl Cancer Inst; 1981 Nov; 67(5):1117-22. PubMed ID: 6946249
[TBL] [Abstract][Full Text] [Related]
14. Metabolism and mutagenicity of N-nitroso-2-methoxy-2,6-dimethylmorpholine in hamsters.
Gingell R; Brunk G; Nagel D; Wallcave L; Walker B; Pour P
J Natl Cancer Inst; 1980 Jan; 64(1):157-61. PubMed ID: 6928040
[TBL] [Abstract][Full Text] [Related]
15. NTP Technical Report on the comparative toxicity studies of allyl acetate (CAS No. 591-87-7), allyl alcohol (CAS No. 107-18-6) and acrolein (CAS No. 107-02-8) administered by gavage to F344/N rats and B6C3F1 mice.
Irwin RD
Toxic Rep Ser; 2006 Jul; (48):1-73, A1-H10. PubMed ID: 17160105
[TBL] [Abstract][Full Text] [Related]
16. Salmonella/human S9 mutagenicity test: a collaborative study with 58 compounds.
Hakura A; Shimada H; Nakajima M; Sui H; Kitamoto S; Suzuki S; Satoh T
Mutagenesis; 2005 May; 20(3):217-28. PubMed ID: 15843387
[TBL] [Abstract][Full Text] [Related]
17. Comparison of mutagenicities of N-nitrosamines on Salmonella typhimurium TA100 and Escherichia coli WP2 uvrA/pKM101 using rat and hamster liver s9.
Araki A; Muramatsu M; Matsushima T
Gan; 1984 Jan; 75(1):8-16. PubMed ID: 6373472
[TBL] [Abstract][Full Text] [Related]
18. Carcinogenicity and mutagenicity of N-nitroso compounds.
Lijinsky W
Mol Toxicol; 1987; 1(1):107-19. PubMed ID: 3329700
[TBL] [Abstract][Full Text] [Related]
19. Metabolism of pancreatic carcinogens N-nitroso-2,6-dimethylmorpholine and N-nitrosobis(2-oxopropyl)amine by microsomes and cytosol of hamster pancreas and liver.
Kokkinakis DM; Scarpelli DG; Rao MS; Hollenberg PF
Cancer Res; 1983 Dec; 43(12 Pt 1):5761-7. PubMed ID: 6640529
[TBL] [Abstract][Full Text] [Related]
20. Carcinogenic potency of N-nitrosomethyl(2-hydroxypropyl)amine and other metabolic relatives of N-nitrosobis(2-hydroxypropyl)amine by single intraperitoneal injection on the lung of rats.
Yokose Y; Yamamoto K; Nakajima A; Eimoto H; Maruyama H; Mori Y; Konishi Y
Jpn J Cancer Res; 1988 Jun; 79(6):698-704. PubMed ID: 3137196
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
